INS and type 2 diabetes mellitus: The results of the First Basal Insulin Evaluation Asia study in 2015 compared the use of insulin therapy and oral hypoglycemic agents, HbA1c levels, and comorbidities in patients with type 2 diabetes in Asian countries.